JP2012510803A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012510803A5 JP2012510803A5 JP2011539034A JP2011539034A JP2012510803A5 JP 2012510803 A5 JP2012510803 A5 JP 2012510803A5 JP 2011539034 A JP2011539034 A JP 2011539034A JP 2011539034 A JP2011539034 A JP 2011539034A JP 2012510803 A5 JP2012510803 A5 JP 2012510803A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated
- isolated peptide
- nucleic acid
- protease
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 108091005804 Peptidases Proteins 0.000 claims 7
- 239000004365 Protease Substances 0.000 claims 7
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 6
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 229940122199 Insulin secretagogue Drugs 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 108090000317 Chymotrypsin Proteins 0.000 claims 1
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 claims 1
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 claims 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical group C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 102000035195 Peptidases Human genes 0.000 claims 1
- 241000235648 Pichia Species 0.000 claims 1
- 102000007562 Serum Albumin Human genes 0.000 claims 1
- 108010071390 Serum Albumin Proteins 0.000 claims 1
- 108090000631 Trypsin Proteins 0.000 claims 1
- 102000004142 Trypsin Human genes 0.000 claims 1
- 229960002376 chymotrypsin Drugs 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 238000010254 subcutaneous injection Methods 0.000 claims 1
- 239000012588 trypsin Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12013508P | 2008-12-05 | 2008-12-05 | |
| US61/120,135 | 2008-12-05 | ||
| PCT/EP2009/066395 WO2010063818A2 (en) | 2008-12-05 | 2009-12-04 | Methods for selecting protease resistant polypeptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015147120A Division JP2015231380A (ja) | 2008-12-05 | 2015-07-24 | プロテアーゼ耐性ポリペプチドを選択するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012510803A JP2012510803A (ja) | 2012-05-17 |
| JP2012510803A5 true JP2012510803A5 (cg-RX-API-DMAC7.html) | 2013-01-31 |
| JP5840498B2 JP5840498B2 (ja) | 2016-01-06 |
Family
ID=42169477
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011539034A Active JP5840498B2 (ja) | 2008-12-05 | 2009-12-04 | プロテアーゼ耐性ポリペプチドを選択するための方法 |
| JP2015147120A Pending JP2015231380A (ja) | 2008-12-05 | 2015-07-24 | プロテアーゼ耐性ポリペプチドを選択するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015147120A Pending JP2015231380A (ja) | 2008-12-05 | 2015-07-24 | プロテアーゼ耐性ポリペプチドを選択するための方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US8685895B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2364326B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5840498B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101740066B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102307897B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009324037B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0922772B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2745448C (cg-RX-API-DMAC7.html) |
| EA (1) | EA026508B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2688621T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL212923A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2011005874A (cg-RX-API-DMAC7.html) |
| SG (1) | SG194383A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010063818A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201103575B (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2364326B1 (en) * | 2008-12-05 | 2018-07-04 | Glaxo Group Limited | Methods for selecting protease resistant polypeptides |
| WO2012020143A1 (en) * | 2010-08-13 | 2012-02-16 | Glaxo Group Limited | Improved anti-serum albumin binding variants |
| EP2606065A2 (en) * | 2010-08-20 | 2013-06-26 | GlaxoSmithKline Intellectual Property Development Limited | Improved anti-serum albumin binding variants |
| EP2866029B1 (en) * | 2012-06-22 | 2017-05-03 | Olympus Corporation | Method for preparing sample containing pancreatic juice component, and kit for storing biological sample containing pancreatic juice component at room temperature |
| CA2918221A1 (en) * | 2013-07-15 | 2015-01-22 | North Carolina State University | Protease-resistant peptide ligands |
| PL3039038T3 (pl) * | 2013-08-30 | 2021-04-19 | Aprilbio Co., Ltd | Konstrukt fuzyjny z fab przeciwko albuminie surowicy i ugrupowania efektorowego oraz sposób jego przygotowania |
| US10294306B2 (en) * | 2015-05-28 | 2019-05-21 | Bio-Rad Laboratories, Inc. | Affinity ligands and methods relating thereto |
| TWI726889B (zh) * | 2015-06-10 | 2021-05-11 | 英商梅迪繆思有限公司 | 蛋白酶抗性之脂化肽 |
| JP6766253B2 (ja) * | 2017-03-28 | 2020-10-07 | 森永乳業株式会社 | 新規ビフィドバクテリウム属細菌 |
| WO2020176678A1 (en) * | 2019-02-26 | 2020-09-03 | Twist Bioscience Corporation | Variant nucleic acid libraries for glp1 receptor |
| US11584781B2 (en) * | 2019-12-30 | 2023-02-21 | Eligo Bioscience | Chimeric receptor binding proteins resistant to proteolytic degradation |
| KR20210095781A (ko) | 2020-01-24 | 2021-08-03 | 주식회사 에이프릴바이오 | 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물 |
| AU2021331088A1 (en) | 2020-08-26 | 2023-05-04 | Twist Bioscience Corporation | Methods and compositions relating to glp1r variants |
| US12122817B2 (en) * | 2020-09-22 | 2024-10-22 | Serpentide Inc. | Long-lasting GLP1 analogue drug for type-2 diabetes |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8725529D0 (en) | 1987-10-30 | 1987-12-02 | Delta Biotechnology Ltd | Polypeptides |
| JP3095168B2 (ja) | 1988-02-05 | 2000-10-03 | エル. モリソン,シェリー | ドメイン‐変性不変部を有する抗体 |
| DE68927933T2 (de) | 1988-09-02 | 1997-08-14 | Dyax Corp | Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen |
| ATE92107T1 (de) | 1989-04-29 | 1993-08-15 | Delta Biotechnology Ltd | N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen. |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5977307A (en) | 1989-09-07 | 1999-11-02 | Alkermes, Inc. | Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| AU8507191A (en) | 1990-08-29 | 1992-03-30 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| EP1046421B8 (en) | 1990-12-06 | 2006-01-11 | Affymetrix, Inc. (a Delaware Corporation) | Methods and reagents for very large scale immobilized polymer synthesis |
| WO1993011236A1 (en) | 1991-12-02 | 1993-06-10 | Medical Research Council | Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| CA2163345A1 (en) | 1993-06-16 | 1994-12-22 | Susan Adrienne Morgan | Antibodies |
| US5702892A (en) | 1995-05-09 | 1997-12-30 | The United States Of America As Represented By The Department Of Health And Human Services | Phage-display of immunoglobulin heavy chain libraries |
| EP0859841B1 (en) | 1995-08-18 | 2002-06-19 | MorphoSys AG | Protein/(poly)peptide libraries |
| EP1019496B1 (en) | 1997-07-07 | 2004-09-29 | Medical Research Council | In vitro sorting method |
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| GB2361237A (en) | 1998-05-13 | 2001-10-17 | Diversys Ltd | Selection system |
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| GB2375112A (en) | 2000-02-03 | 2002-11-06 | Domantis Ltd | Combinatorial protein domains |
| DK1355942T3 (da) | 2000-12-07 | 2008-11-17 | Lilly Co Eli | GLP-1-fusionsproteiner |
| WO2002095076A2 (en) | 2001-05-23 | 2002-11-28 | Kabushiki Kaisha Toyota Chuo Kenkyusho | Modified polypeptides having protease-resistance and/or protease-sensitivity |
| DE60224284T2 (de) | 2001-06-28 | 2008-12-18 | Novo Nordisk A/S | Stabile formulierung von modifiziertem glp-1 |
| WO2005003296A2 (en) | 2003-01-22 | 2005-01-13 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US20080108560A1 (en) | 2002-03-05 | 2008-05-08 | Eli Lilly And Company | Heterologous G-Csf Fusion Proteins |
| US7696320B2 (en) * | 2004-08-24 | 2010-04-13 | Domantis Limited | Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor |
| US9321832B2 (en) | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
| US20060002935A1 (en) | 2002-06-28 | 2006-01-05 | Domantis Limited | Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor |
| CA2505326A1 (en) | 2002-11-08 | 2004-05-21 | Ablynx N.V. | Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders |
| JP4949838B2 (ja) | 2003-09-19 | 2012-06-13 | ノヴォ ノルディスク アー/エス | 新規glp−1誘導体 |
| DK1737962T3 (da) | 2004-03-24 | 2010-12-13 | Domantis Ltd | GAS1-universel leder |
| SG157423A1 (en) * | 2004-12-02 | 2009-12-29 | Domantis Ltd | Bispecific domain antibodies targeting serum albumin and glp-1 or pyy |
| US8841413B2 (en) * | 2006-10-03 | 2014-09-23 | Cadila Healthcare Limited | Antidiabetic compounds |
| GB0724331D0 (en) * | 2007-12-13 | 2008-01-23 | Domantis Ltd | Compositions for pulmonary delivery |
| MX2010010776A (es) * | 2008-03-31 | 2010-10-26 | Glaxo Group Ltd | Fusiones y conjugados de farmaco. |
| EP2364326B1 (en) * | 2008-12-05 | 2018-07-04 | Glaxo Group Limited | Methods for selecting protease resistant polypeptides |
| ES2654929T3 (es) * | 2009-02-19 | 2018-02-15 | Glaxo Group Limited | Variantes de unión de anti-albúmina de suero mejoradas |
-
2009
- 2009-12-04 EP EP09764259.9A patent/EP2364326B1/en active Active
- 2009-12-04 BR BRPI0922772-5A patent/BRPI0922772B1/pt active IP Right Grant
- 2009-12-04 ES ES09764259.9T patent/ES2688621T3/es active Active
- 2009-12-04 MX MX2011005874A patent/MX2011005874A/es not_active Application Discontinuation
- 2009-12-04 CN CN200980156194.1A patent/CN102307897B/zh active Active
- 2009-12-04 AU AU2009324037A patent/AU2009324037B2/en not_active Ceased
- 2009-12-04 SG SG2013073069A patent/SG194383A1/en unknown
- 2009-12-04 KR KR1020117015383A patent/KR101740066B1/ko not_active Expired - Fee Related
- 2009-12-04 EA EA201170762A patent/EA026508B1/ru not_active IP Right Cessation
- 2009-12-04 CA CA2745448A patent/CA2745448C/en active Active
- 2009-12-04 JP JP2011539034A patent/JP5840498B2/ja active Active
- 2009-12-04 US US13/131,640 patent/US8685895B2/en active Active
- 2009-12-04 WO PCT/EP2009/066395 patent/WO2010063818A2/en not_active Ceased
-
2011
- 2011-05-16 ZA ZA2011/03575A patent/ZA201103575B/en unknown
- 2011-05-16 IL IL212923A patent/IL212923A0/en unknown
-
2014
- 2014-02-10 US US14/176,231 patent/US10466252B2/en active Active
-
2015
- 2015-07-24 JP JP2015147120A patent/JP2015231380A/ja active Pending
-
2017
- 2017-08-17 US US15/679,191 patent/US10302655B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012510803A5 (cg-RX-API-DMAC7.html) | ||
| JP2023179436A5 (cg-RX-API-DMAC7.html) | ||
| US20130040877A1 (en) | Long-acting y2 receptor agonists | |
| NZ596778A (en) | Glucose-regulating polypeptides and methods of making and using same | |
| NZ597685A (en) | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli | |
| JP2010529860A5 (cg-RX-API-DMAC7.html) | ||
| JP2014510518A5 (cg-RX-API-DMAC7.html) | ||
| JP2013545724A5 (cg-RX-API-DMAC7.html) | ||
| JP2007513634A5 (cg-RX-API-DMAC7.html) | ||
| JP2010529849A (ja) | グルカゴン類似体 | |
| JP2016512213A5 (cg-RX-API-DMAC7.html) | ||
| EA200901108A1 (ru) | Соагонисты глюкагоновых/glp-1-рецепторов | |
| JP2016512213A (ja) | 肥満の治療のためのペグ化グルカゴン及びglp−1コアゴニスト | |
| US20210221866A1 (en) | Protease-resistant lipidated glp-1 analogs | |
| JP2015504052A5 (cg-RX-API-DMAC7.html) | ||
| MX2008009493A (es) | Peptido novedoso y uso del mismo. | |
| WO2010007144A3 (en) | Mutated netrin-4 proteins, fragments thereof and their uses as drugs | |
| EP4476248A1 (en) | Glp-1 and glucagon dual agonist peptides with improved biological stability | |
| CY1111630T1 (el) | Παραγωγα κυτοκινων | |
| KR20190017017A (ko) | 프로테아제-내성 모노-지질화된 펩타이드 | |
| WO2006111946A3 (en) | Toll-like receptor 14 (tlr14 ) and use thereof | |
| JP2020511425A5 (cg-RX-API-DMAC7.html) | ||
| JP2008517998A5 (cg-RX-API-DMAC7.html) | ||
| WO2007064844A3 (en) | Anti-viral griffithsin compounds, compositions, and methods of use | |
| CN120530127A (zh) | 新型三重glp-1/gip/胰高血糖素受体激动剂及包括其的用于预防或治疗肥胖症的药物组合物 |